The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein
Open accessAbstract
The mammalian immune system discriminates between modes of cell death; necrosis often results in inflammation and adaptive immunity, whereas apoptosis tends to be anti-inflammatory and promote immune tolerance. We have examined apoptosis for the features responsible for tolerance; specifically, we looked at the roles of caspases and mitochondria. Our results show that caspase activation targeted the mitochondria to produce reactive oxygen species (ROS), which were critical to tolerance induction by apoptotic cells. ROS oxidized the potential danger signal high-mobility group box-1 protein (HMGB1) released from dying cells and thereby neutralized its stimulatory activity. Apoptotic cells failed to induce tolerance and instead stimulated immune responses by scavenging or by mutating a mitochondrial caspase target protein when ROS activity was prohibited. Similarly, blocking sites of oxidation in HMGB1 prevented tolerance induction by apoptotic cells. These results suggest that caspase-orchestrated mitochondrial events determine the impact of apoptotic cells on the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“That said, it should be noted that biological activities of HMGB1 may flip from pro-inflammatory to anti-inflammatory depending on multiple variables including its oxidation state [917–923].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [921]
In the citing paper
“Potential immunogenic signals emanating from dying cells include proteins that appear at the surface of stressed and dying cells (such as calreticulin and heat shock proteins, HSPs), lipid moieties that flip from the inner plasma membrane leaflet to the outer leaflet (such as phosphatidylserine) 38,60, proteins that are released into the supernatant of cells (such as HMGB1) 51, as well as nucleic”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
In the citing paper
“The inhibition of caspases affects the exposure of find-me signals 40, eat-me signals 40 (Box 4), and the secretion of DAMPs51 from dying cells, as well as the exposure of CRT on anthracyclin-treated cancer cells60.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
In the citing paper
“Thus, HMGB1 may act on the receptor for advanced glycated endproducts (RAGEs) and possibly the toll-like receptors (TLRs) including TLR2 and TLR4 51,52, although the latter are controversial 53.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 4×
“Although these mediators can stimulate immunity, apoptotic cells can inhibit inflammatory and immunological responses driven by macrophages and DCs (Fadok et al., 1998).”
BackgroundInfluentialSteinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
Apoptosis: controlled demolition at the cellular level
Taylor, R. C., Cullen, S. P., & Martin, S. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2312 · Cited by 2,708
Mitochondria, oxidative stress and cell death
Ott, M., Gogvadze, V. G., Orrenius, S., & Zhivotovsky, B. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0756-2 · Cited by 2,020
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 626
Escamilla-Tilch, M., Filio‐Rodríguez, G., García‐Rocha, R., Mancilla‐Herrera, I., Mitchison, N. A., Ruiz‐Pacheco, J. A., Sánchez‐García, F. J., Sandoval‐Borrego, D., & Vázquez-Sánchez, E. A. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.58 · Cited by 87
Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response
Zhao, C., Wang, C., Shan, W., Wang, Z., Chen, X. S., & Deng, H. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00771 · Cited by 86
Inflammasome: Cancer's friend or foe?
Terlizzi, M., Casolaro, V., Pinto, A., & Sorrentino, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.002 · Cited by 87
The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer
Diener, K. R., Al‐Dasooqi, N., Lousberg, E. L., & Hayball, J. D. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.25 · Cited by 84
Urbonaviciute, V., & Voll, R. E. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02432.x · Cited by 85
Liu, Z., Falo, L. D., & You, Z. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003378 · Cited by 83
Cantoni, C., Huergo-Zapico, L., Parodi, M., Pedrazzi, M., Mingari, M. C., Moretta, A., Sparatore, B., Gonzalez, S. R., Olive, D., Bottino, C., et al. (2016) · Journal of Immunology Research · doi:10.1155/2016/4684268 · Cited by 85
Therapeutic applications of TRAIL receptor agonists in cancer and beyond
Amarante-Mendes, G. P., & Griffith, T. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.09.001 · Cited by 83
Ge, Y., Huang, M., & Yao, Y.-M. (2021) · Cells · doi:10.3390/cells10051044 · Cited by 86
Koenig, A., & Buskiewicz, I. A. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0073 · Cited by 78
RIPK3-Mediated Necroptosis Regulates Cardiac Allograft Rejection
Pavlosky, A., Lau, A., Su, Y., Lian, D., Huang, X., Yin, Z., Haig, A. R., Jevnikar, A. M., & Zhang, Z.-X. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12779 · Cited by 82
HMGB1 in the interplay between autophagy and apoptosis in cancer
Chen, R., Zou, J., Zhong, X. Y., Li, J., Kang, R., & Tang, D. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216494 · Cited by 80
Zhang, L., Deng, S., Zhao, S., Ai, Y., Zhang, L., Pan, P., Su, X., Tan, H., & Wu, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091425 · Cited by 78
The translocation of HMGB1 during cell activation and cell death
Gauley, J., & Pisetsky, D. S. (2009) · Autoimmunity · doi:10.1080/08916930902831522 · Cited by 81
LeBlanc, P. M., Doggett, T. A., Choi, J., Hancock, M. A., Durocher, Y., Frank, F., Nagar, B., Ferguson, T. A., & Saleh, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541474 · Cited by 79
Self-citationCarbon‐ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma
Matsunaga, A., Ueda, Y., Yamada, S., Harada, Y., Shimada, H., Hasegawa, M., Tsujii, H., Ochiai, T., & Yonemitsu, Y. (2010) · Cancer · doi:10.1002/cncr.25134 · Cited by 77
Immunological aspects of antitumor photodynamic therapy outcome
Wachowska, M., Muchowicz, A., & Demkow, U. A. (2016) · Central European Journal of Immunology · doi:10.5114/ceji.2015.56974 · Cited by 76
Castellani, P., Balza, E., & Rubartelli, A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5164 · Cited by 86
Pisetsky, D. S. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00014 · Cited by 76
Lurje, I., Werner, W., Mohr, R. U., Roderburg, C., Tacke, F., & Hammerich, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650486 · Cited by 79
Barrientos, L., Bignon, A., Guéguen, C., de Chaisemartin, L., Gorges, R., Sandré, C., Mascarell, L., Balabanian, K., Kerdine‐Römer, S., Pallardy, M. J., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400586 · Cited by 87
Dallio, M., Sangineto, M., Romeo, M., Villani, R., Romano, A. D., Loguercio, C., Serviddio, G., & Federico, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010436 · Cited by 77
HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation
Li, J., Wang, Z., Li, J., Zhao, H., & Ma, Q. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01258-5 · Cited by 81
The Role of HMGB1 in Cardiovascular Biology: Danger Signals
Cai, J., Wen, J., Bauer, E. M., Zhong, H., Yuan, H., & Chen, A. F. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6408 · Cited by 72
Vezzoli, M., Castellani, P., Corna, G., Castiglioni, A., Bosurgi, L., Monno, A., Brunelli, S., Manfredi, A. A., Rubartelli, A., & Rovere, P. Q. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3341 · Cited by 76
Cell death in the pathogenesis of immune-mediated diseases
Pisetsky, D. S. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13256 · Cited by 74
Abdominal drains: a brief historical review.
Memon, M. A., Memon, M. A., & Donohue, J. H. (2001) · PubMed · Cited by 72
Life after death: targeting high mobility group box 1 in emergent cancer therapies.
Guo, Z. S., Liu, Z., Bartlett, D. L., Tang, D., & Lotze, M. T. (2013) · Europe PMC (PubMed Central) · Cited by 72
Unsinger, J., Kazama, H., McDonough, J. S., Griffith, T. S., Hotchkiss, R. S., & Ferguson, T. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904054 · Cited by 77
Self-citationBehl, T., Sharma, E., Sehgal, A., Kaur, I., Kumar, A., Arora, R., Pal, G., Kakkar, M., Kaundal, R. K., & BUNGAU, S. G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06130-x · Cited by 73
The machinery of Nod‐like receptors: refining the paths to immunity and cell death
Saleh, M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01045.x · Cited by 74
Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases
Schmidt, E. P., & Tuder, R. M. (2010) · Journal of Cell Death · doi:10.4137/jcd.s5375 · Cited by 70
Prakash, A., Mesa, K. R., Wilhelmsen, K., Xu, F., Dodd‐o, J. M., & Hellman, J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31826a4ae3 · Cited by 70
Tadié, J., Bae, H., Deshane, J. S., Bell, C. P., Lazarowski, E. R., Chaplin, D., Thannickal, V. J., Abraham, E. H., & Zmijewski, J. W. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00401 · Cited by 70
Extracellular DNA and autoimmune diseases
Lou, H., & Pickering, M. C. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.136 · Cited by 71
Scientific and Clinical Challenges in Sepsis
Ulloa, L., Brunner, M., Ramos, L., & Deitch, E. A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453248 · Cited by 66
Apoptosis: A Programme of Cell Death or Cell Disposal?
Pereira, W. O., & Amarante-Mendes, G. P. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02513.x · Cited by 72
Liu, H., Innamarato, P., Kodumudi, K. N., Weber, A. M., Nemoto, S., Robinson, J. L., Crago, G., McCardle, T. W., Royster, E. B., Sarnaik, A. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9247 · Cited by 67
Xia, C., Campbell, K. A., & Clare-Salzler, M. J. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32832ce943 · Cited by 66
Heiser, R. A., Cao, A., Zeng, W., Ulrich, M. L., Younan, P., Anderson, M. E., Trueblood, E. S., Jonas, M., Thurman, R., Law, C., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0118 · Cited by 75
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
Pilzweger, C., & Holdenrieder, S. (2015) · Diagnostics · doi:10.3390/diagnostics5020219 · Cited by 67
The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis
Chen, Y., Sun, W., Gao, R., Su, Y., Umehara, H., Dong, L., & Gong, F. (2013) · Rheumatology · doi:10.1093/rheumatology/ket134 · Cited by 66
The complex roles of efferocytosis in cancer development, metastasis, and treatment
Tajbakhsh, A., Gheibi hayat, S. M., Movahedpour, A., Savardashtaki, A., Loveless, R., Barreto, G. E., Teng, Y., & Sahebkar, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111776 · Cited by 64
Immunogenic Cell Death in Hematological Malignancy Therapy
Liu, Z., Xu, X., Liu, K., Zhang, J., Ding, D., & Fu, R. (2023) · Advanced Science · doi:10.1002/advs.202207475 · Cited by 63
Functional Aspects of Redox Control During Neuroinflammation
Rosales‐Corral, S., Reiter, R. J., Tan, D., Ortiz, G. G., & López-Armas, G. D. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2629 · Cited by 66
Lau, A. N., Wang, S., Liu, W., Haig, A. R., Zhang, Z., & Jevnikar, A. M. (2014) · American Journal of Nephrology · doi:10.1159/000364908 · Cited by 64
Robinson, A. P., Caldis, M. W., Harp, C. T., Goings, G. E., & Miller, S. D. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.02.005 · Cited by 64
Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development
Rafikova, O., Ghouleh, I. A., & Rafikov, R. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7673 · Cited by 66
Taverna, S., Tonacci, A., Ferraro, M., Cammarata, G., Cuttitta, G., Bucchieri, S., Pace, E., & Gangemi, S. (2022) · Cells · doi:10.3390/cells11050849 · Cited by 64
McGaha, T. L., & Karlsson, M. C. I. (2015) · Immunological Reviews · doi:10.1111/imr.12382 · Cited by 64
Immunogenicity of necrotic cell death
Gamrekelashvili, J., Greten, T. F., & Korangy, F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1741-x · Cited by 63
Wang, R., Meng, H., Kou, X., Sui, B., Sanmillan, M. L., Zhang, X., Liu, D., Tian, J., Yu, W., Chen, C., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.026 · Cited by 61
Yong, J., & Toh, C. (2023) · Blood · doi:10.1182/blood.2023021166 · Cited by 68
HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.
Zhang, S., Zhong, J., Yang, P. C., Gong, F., & Wang, C. (2009) · PubMed Central · Cited by 61
Microbe- and danger-induced inflammation
Broggi, A., & Granucci, F. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.037 · Cited by 60
Activated macrophages in the tumour microenvironment—dancing to the tune of TLR and NF‐κB
Hallam, S. L., Escorcio‐Correia, M., Soper, R., Schultheiss, A., & Hagemann, T. (2009) · The Journal of Pathology · doi:10.1002/path.2602 · Cited by 62
Negishi, Y., Shima, Y., Takeshita, T., & Morita, R. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1809951 · Cited by 62
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosis
van Delft, M. F., Chappaz, S., Khakham, Y., Bui, C. T., Debrincat, M. A., Lowes, K. N., Brouwer, J. M., Grohmann, C., Sharp, P. P., Dagley, L. F., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0365-8 · Cited by 56
Molecular determinants of immunogenic cell death elicited by radiation therapy
Galassi, C., Klapp, V., Yamazaki, T., & Galluzzi, L. (2023) · Immunological Reviews · doi:10.1111/imr.13271 · Cited by 65
Redox modifications of cysteine residues regulate the cytokine activity of HMGB1
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Vénéreau, E., Bianchi, M. E., Al‐Abed, Y., Andersson, U., & Tracey, K. J. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00307-1 · Cited by 59
Immunological nanomaterials to combat cancer metastasis
Pan, Y., Cheng, J., Zhu, Y., Zhang, J., Fan, W., & Chen, X. S. (2024) · Chemical Society Reviews · doi:10.1039/d2cs00968d · Cited by 58
The immunobiology of the receptor of advanced glycation end-products: Trends and challenges
González, I., Romero, J. A., Rodríguez, B. L., Pérez-Castro, R., & Armando Rojas, R. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.09.005 · Cited by 59
Zhu, S., Li, W., Ward, M. F., Sama, A. E., & Wang, H. (2010) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152810791292872 · Cited by 57
HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells
Gougeon, M.-L., Melki, M.-T., & Saïdi, H. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.134 · Cited by 58
Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury
Lu, H., Zhang, Z., Barnie, P. A., & Su, Z. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.05.009 · Cited by 55
Ménage à Trois in stress: DAMPs, redox and autophagy
Li, G., Tang, D., & Lotze, M. T. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.002 · Cited by 55
The Translocation of Nuclear Molecules During Inflammation and Cell Death
Pisetsky, D. S. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5143 · Cited by 57
Role of Damage-Associated Molecular Patterns in Septic Acute Kidney Injury, From Injury to Recovery
Ludes, P., de Roquetaillade, C., Chousterman, B. G., Pottecher, J., & Mebazaa, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.606622 · Cited by 54
Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
Wang, W., Zhang, L., & Sun, Z. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0049 · Cited by 54
Recent Developments in the Role of High-Mobility Group Box 1 in Systemic Lupus Erythematosus
Schaper, F., Westra, J., & Bijl, M. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00019 · Cited by 54
Schildkopf, P., Frey, B., Mantel, F., Ott, O. J., Weiss, E., Sieber, R., Janko, C., Sauer, R., Fietkau, R., & Gaipl, U. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.008 · Cited by 57
Peng, R.-Q., Wu, X.-J., Ding, Y., Li, C.-Y., Yu, X.-J., Zhang, X., Wan, D.-S., Wan, D.-S., Zeng, Y.-X., Zeng, Y.-X., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-496 · Cited by 53
Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation
Jiang, M., Gu, D.-N., Dai, J., Huang, Q., & Tian, L. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.01.018 · Cited by 54
Qiao, X., Li, W., Zheng, Z., Liu, C., Zhao, L., He, Y., & Li, H. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.82003 · Cited by 53
Liu, A., Fang, H., Dirsch, O., Jin, H., & Dahmen, U. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035379 · Cited by 52
Saas, P., Daguindau, É., & Perruche, S. (2016) · Stem Cells · doi:10.1002/stem.2361 · Cited by 53
Interferon-γ Regulates the Death ofM. tuberculosis-InfectedMacrophages
Lee, J., & Kornfeld, H. (2010) · Journal of Cell Death · doi:10.4137/jcd.s2822 · Cited by 52
IL‐1β/HMGB1 Complexes Promote The PGE2 Biosynthesis Pathway in Synovial Fibroblasts
Leclerc, P. M., Wähämaa, H., Idborg, H., Jakobsson, P., Harris, H. E., & Korotkova, M. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12041 · Cited by 52
Xiao, Y., Wigginton, J. G., Maass, D. L., Ma, L., Carlson, D., Wolf, S. E., Minei, J. P., & Zang, Q. S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00475.2013 · Cited by 52
Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke
Richard, S. A., Sackey, M., Su, Z., & Hua-xi, X. (2017) · Bioscience Reports · doi:10.1042/bsr20171104 · Cited by 51
The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE
Pisetsky, D. S. (2014) · Autoimmunity · doi:10.3109/08916934.2014.921811 · Cited by 51
Cary, Z. D., Willingham, M. C., & Lyles, D. S. (2011) · Journal of Virology · doi:10.1128/jvi.02393-10 · Cited by 51
Yang, R., & Zhang, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.984835 · Cited by 50
HMGB1 and Microparticles as Mediators of the Immune Response to Cell Death
Pisetsky, D. S., Gauley, J., & Ullal, A. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3865 · Cited by 50
Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity
Lecis, D., Cesare, M. D., Perego, P., Conti, A., Corna, E., Drago, C., Seneci, P., Walczak, H., Colombo, M. P., Delia, D., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.449 · Cited by 50
RETRACTED: Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis
Kaur, I., Behl, T., BUNGAU, S. G., Kumar, A., Mehta, V., Setia, D., Uddin, M. S., Zengin, G., Aleya, L., & Arora, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118164 · Cited by 50
RetractedBiological functions and theranostic potential of HMGB family members in human cancers
Niu, L., Yang, W., Duan, L., Wang, X., Li, Y., Xu, C., Liu, C., Zhang, Y., Zhou, W. J., Liu, J., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920970850 · Cited by 51
Palmblad, K., Schierbeck, H., Sundberg, E., Horne, A., Harris, H. E., Henter, J., Antoine, D. J., & Andersson, U. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00183 · Cited by 50
RetractedLi, H.-N., Barlow, P. G., Bylund, J., Mackellar, A., Björstad, Å., Conlon, J., Hiemstra, P. S., Haslett, C., Gray, M., Simpson, A. J., et al. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209050 · Cited by 49
Unconventional Pathways of Secretion Contribute to Inflammation
Daniels, M. J. D., & Brough, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010102 · Cited by 50
Stojanovska, V., McQuade, R. M., Fraser, S., Prakash, M. D., Gondalia, S. V., Stavely, R. G., Palombo, E. A., Apostolopoulos, V., Sakkal, S., & Nurgali, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198359 · Cited by 48
Monaco, H., Yokomizo, S., Choi, H. S., & Kashiwagi, S. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200110 · Cited by 51
Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword
Wang, J., Liu, N., Jiang, H., Qian, L., & Xing, D. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.784612 · Cited by 48
High Mobility Group Box 1 (HMGB1): Molecular Signaling and Potential Therapeutic Strategies
Datta, S., Rahman, M. A., Koka, S., & Boini, K. M. (2024) · Cells · doi:10.3390/cells13231946 · Cited by 48
The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells
Zanetti, M., Rodvold, J. J., & Mahadevan, N. R. (2015) · Oncogene · doi:10.1038/onc.2015.108 · Cited by 49
Singh, B., Modica-Napolitano, J. S., & Singh, K. K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.004 · Cited by 49
Introduction: HMGB1 in inflammation and innate immunity
Andersson, J., & Rauvala, H. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02430.x · Cited by 48
Metabolic Rewiring and Redox Alterations in Malignant Pleural Mesothelioma
Urso, L., Cavallari, I., Sharova, E., Ciccarese, F., Pasello, G., & Ciminale, V. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0661-9 · Cited by 47
Barsheshet, Y., Voloshin, T., Brant, B., Cohen, G., Koren, L., Blatt, R., Cahal, S., Khalil, T. H., Tov, E. Z., Paz, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214073 · Cited by 49
Mitochondrial Reactive Oxygen Species and Lytic Programmed Cell Death in Acute Inflammation
Rius‐Pérez, S., Pérez, S., Tolédano, M. B., & Sastre, J. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0209 · Cited by 48
Metadata
- Authors
- Kazama, H., Ricci, J.-E., Herndon, J. M., Hoppe, G., Green, D. R., & Ferguson, T. A.
- Affiliations
- Washington University in St. Louis (US)
- Université Côte d'Azur (FR)
- Cleveland Clinic (US)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Ferguson, Thomas A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 29
- Issue
- 1
- Pages
- 21-32
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC2704496
- OpenAlex
- W2084623259
- Cited by
- 627
- References
- 60
- Citations by year
- 2026: 24 · 2025: 23 · 2024: 33 · 2023: 35 · 2022: 24 · 2021: 38 · 2020: 32 · 2019: 26 · 2018: 33 · 2017: 31 · 2016: 20 · 2015: 44 · 2014: 47 · 2013: 43 · 2012: 34
- FWCI
- 19.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Research to Prevent Blindness (EY02687)
- National Institutes of Health (AI44848, EY02687, EY06765)
- National Eye Institute (EY 02687, P30EY002687, EY 015570, F32EY006765, EY06765, R01EY015570, R01EY006765)
- National Institute of Allergy and Infectious Diseases (AI44848, R01AI044828, R01AI040646)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- immune tolerance, apoptotic cells, caspases, HMGB1, high mobility group box 1 protein, reactive oxygen species, oxidative modification, damage-associated molecular patterns, necrosis, tolerance induction
- MeSH terms
- Animals, Dendritic Cells, HeLa Cells, Humans, Immune Tolerance, Mice, Inbred C57BL, Mitochondria, Oxidation-Reduction, Immunoblotting, Apoptosis, Reactive Oxygen Species, Caspases, HMGB1 Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
